Find Academic Supervisors

Ting DuView profile

Assistant Professor

• Neuroscience
• Neurology
• Brain Fluid Homeostasis
• +7 more

Ting Du, M.D., Ph.D., is an Assistant Professor in the Department of Neurology at the University of Rochester Medical Center's School of Medicine and Dentistry. She leads the Du Lab, focusing on brain fluid homeostasis and its role in neurological diseases. Faculty: Assistant Professor, Department of Neurology Institution: University of Rochester Medical Center Lab: Du Lab Collaborations: Nedergaard Lab, Center for Translational Neuromedicine Research Interests: The Du Lab investigates cerebrospinal fluid (CSF) dynamics, glymphatic system function, and cervical lymphatic vessels in Alzheimer's disease, hydrocephalus, and traumatic brain injury. Key projects include: Restoring cervical lymphatic function to improve CSF drainage in aging Characterizing the subarachnoid lymphatic-like membrane (SLYM) in trauma Probing choroid plexus regulation in hydrocephalus Publication Trends: Recent work spans Neuroscience , Neurodegeneration , and Biophysics , with emphasis on: Glymphatic dysfunction in Alzheimer's Arterial pulsation-driven CSF flow Aquaporin-4's role in interstitial fluid Machine learning-based flow quantification Lab Affiliations: The Du Lab is part of the Neuroscience Ph.D. Program and Pathology - Cell Biology of Disease program, collaborating with experts in neuroimaging , fluid dynamics , and neurotherapeutics .

Greg AdamsonView profile

Assistant Clinical Professor

• Pediatric Cardiology
• Interventional Cardiology
• Pulmonary Arterial Hypertension
• +3 more

Greg Adamson is a Clinical Assistant Professor in the Department of Pediatrics - Cardiology at Stanford University School of Medicine and a member of the Maternal & Child Health Research Institute (MCHRI) . He specializes in Interventional Cardiology and Lymphatic Diseases , with clinical expertise in managing conditions like chylothorax and pulmonary arterial hypertension. Medical Education : St. Louis University School of Medicine (2014) Residency : University of California San Francisco (2017) Fellowship : Stanford University Pediatric Cardiology Fellowship (2020) Board Certifications : Pediatrics (2017) and Pediatric Cardiology (2024) Dr. Adamson's research focuses on pediatric pulmonary hypertension , cardiac catheterization protocols , and postoperative chylothorax management . His work includes developing prediction models for early chylothorax detection and evaluating vasopressin's hemodynamic effects in Fontan circulation patients. He has contributed to clinical practice guidelines for progressive pulmonary hypertension in children. His recent publications emphasize procedural efficiency in outpatient cardiac catheterization, valve repair durability in congenital heart disease, and standardized chylothorax algorithms . He utilizes multicenter collaborative frameworks and retrospective cohort analyses , with methodological approaches including logistic regression , Cox proportional hazards modeling , and consensus-building surveys . Key technical areas include lymphatic interventions , hemodynamic monitoring , and predictive analytics in pediatric cardiology. In clinical operations, he investigates same-day discharge criteria for pulmonary hypertension patients and optimal timing for advanced therapies . His work addresses practice variations in chylothorax treatment through quality improvement initiatives , including multidisciplinary algorithm development and ex vivo simulation testing for clinical implementation.

Alice DentonView profile

Lecturer

• Immunology
• Inflammation
• Vaccinology
• +3 more

Dr Alice Denton is a Lecturer in the Centre for Inflammatory Disease at Imperial College London, where she has worked since January 2020. Her research focuses on understanding how fibroblasts influence immune responses during vaccination and aging. She leads a small lab team and has secured significant funding, including an MRC Career Development Award and a Dunhill Medical Trust Seed Award. Education: PhD, University of Melbourne (2006-2010) Postdoc, University of Cambridge (2010-2015) BBSRC FL Fellowship, Babraham Institute (2016-2019) Alice's research explores the interplay between fibroblasts and immune cells in lymph nodes, particularly how inflammation and aging affect fibroblast function. Her work aims to improve vaccine efficacy through better understanding of stromal-immune crosstalk. Key themes include germinal center immunology , lymph node stromal cells , aging immunity , and inflammatory microenvironment . Her recent publications emphasize fibroblast-immune interactions in tertiary lymphoid structures, podoplanin signaling , and TLR4 targeting for vaccine enhancement. She also investigates spatial organization of immune cells during aging and the role of lymphoid stromal cells in supporting macrophages and germinal centers. Scientific Awards: MRC Career Development Award Dunhill Medical Trust Seed Award Alice collaborates with colleagues at Imperial College London and manages multiple responsibilities including teaching, supervision, and lab work. Outside academia, she enjoys baking (especially sourdough bread), creating cat-themed art, and distilling experimental flavors like pea-flavored gin.

• Neuroscience
• Anesthesiology
• Brain Imaging
• +3 more

Dr. Helene Benveniste is a Professor of Anesthesiology at Yale School of Medicine, specializing in neuroimaging and neurodegenerative diseases. She holds a dual background in Mathematics/Physics (BSc, Katedralskolen) and Medicine (MD and PhD in Neurobiology from University of Copenhagen). Her research focuses on the glymphatic system, cerebrospinal fluid dynamics, and brain waste clearance in aging and neurodegenerative diseases like Alzheimer’s. She has pioneered MRI/PET techniques for studying these processes and contributed to understanding cerebral amyloid angiopathy. Affiliations include the Anesthesiology Department, Yale Biomedical Imaging Institute, and the Center for Brain & Mind Health. Collaborators include Douglas Rothman, D. S. Fahmeed Hyder, and Kevin Behar. Her work spans clinical trials (e.g., SEMALCO trial for alcohol use disorder) and translational research, with over 100 publications. Notable 2025 studies address brain aging, CSF pathways, and glymphatic transport mechanisms. Education: • PhD in Neurobiology, University of Copenhagen (1991) • MD, University of Copenhagen (1986) Research Interests: • Glymphatic system function and dysfunction • Cerebrospinal fluid dynamics in health/disease • Neuroimaging techniques (MRI/PET) • Alzheimer’s and other neurodegenerative diseases • Brain clearance pathways in aging Publications Trends: Recent work emphasizes brain aging, CSF transport, and translational applications like clinical trials for alcohol use disorder. Key themes include glymphatic system dysfunction in neurodegeneration, fluid dynamics modeling, and biomarker discovery. Labs/Teams: Leads a research lab at Yale investigating glymphatic pathways and their role in disease. Collaborates with engineering and mathematics teams to model fluid flows using optimal mass transport algorithms.

Paul W BurridgeView profile

Associate Professor

• Pharmacogenomics
• Cardio-Oncology
• Induced Pluripotent Stem Cell Modeling
• +5 more

Paul W Burridge, PhD is an Associate Professor in the Department of Pharmacology at Northwestern University's Feinberg School of Medicine and a founding faculty member of the Center for Pharmacogenomics. His laboratory specializes in human induced pluripotent stem cell (hiPSC) modeling for pharmacogenomics and cardio-oncology research. Dr. Burridge's research focuses on understanding how genomic variation influences drug efficacy and toxicity, particularly in cancer therapy-induced cardiovascular complications. His lab pioneered several key methodologies including the first directed cardiac differentiation protocol, non-integrating blood-to-iPSC reprogramming, and chemically defined differentiation protocols. Current projects span cardio-oncology, arrhythmia mechanisms, regenerative medicine, hiPSC models of breast cancer, and cultivated meat applications. Analysis of his 15 most recent publications reveals a strong emphasis on pharmacogenomics of anthracycline cardiotoxicity, with significant focus on genomic risk prediction in childhood cancer survivors, molecular mechanisms of cardiotoxicity, and development of cardioprotective strategies. His work increasingly integrates large-scale genomic analysis with hiPSC modeling to establish causal relationships between genetic variants and clinical outcomes. Fellow of American Heart Association (2016) Recipient of NCI R01 grant for Nilotinib Induced Artery Disease research NIH NHLBI Pathway to Independence Award recipient Editorial Board Member, Journal of Molecular and Cellular Cardiology (2020-present) Associate Editor, JACC CardioOncology (2018-present) Dr. Burridge advises multiple postdoctoral fellows including Ning Ge (cardiac arrhythmia modeling), Praeploy Pongpamorn (chemically defined differentiation), Nnamdi Uche (population-specific doxorubicin susceptibility), and George Gibbons. His lab has secured substantial grant funding for projects including large-scale hiPSC production, cardiotoxicity screening platforms, and novel drug discovery initiatives. The Burridge lab maintains extensive resources including high-throughput screening systems, CRISPR editing platforms, and bioreactor-based differentiation systems, all developed with a focus on eliminating animal-derived products from research.

Ngan F. HuangView profile

Associate Professor

• Tissue Engineering
• Cardiovascular Regeneration
• Stem Cell Therapy
• +6 more

Ngan F. Huang, PhD is an Associate Professor of Cardiothoracic Surgery at Stanford University and a Courtesy Associate Professor of Chemical Engineering . She serves as a Research Career Scientist at the Department of Veterans Affairs and leads the Huang Research Lab at the Center for Tissue Regeneration, Repair and Restoration (VA Palo Alto Health Care System). Key roles: Principal Investigator, Stanford Cardiovascular Institute Research focus: Tissue Engineering , Cardiovascular Regeneration , Stem Cell Therapy , and Biomaterials Her work leverages extracellular matrix (ECM) cues, nanofibrillar scaffolds , and organ-on-a-chip platforms to address conditions like peripheral artery disease , muscle injury , and cardiovascular dysfunction . Recent publications emphasize combinatorial ECM designs , microgravity muscle modeling , and aligned fibrillar structures for cell orientation. Notable awards include the Peripheral Vascular Disease Travel Award (2014) and Robert W Hobson II Early Career Investigator Award (2012). Her lab actively recruits postdoctoral fellows and animal technicians for studies involving vascular disease models and tissue regeneration .

Roger Dale KammView profile

Professor

• Microfluidics
• Cell mechanics
• Biological systems
• +6 more

Roger Dale Kamm is the Cecil and Ida Green Distinguished Professor at the Massachusetts Institute of Technology (MIT) in the departments of Mechanical Engineering and Biological Engineering . As a leading figure in mechanobiology, he directs the NSF Center on Emergent Behaviors of Integrated Cellular Systems and co-chairs the MIT faculty. His research focuses on microfluidic models for diseases such as metastatic cancer , Alzheimer’s , and ALS , with an emphasis on integrated cellular systems and living machines . His work bridges cell mechanics , biological systems , and vascular engineering , producing organ-on-a-chip and vascularized organoids for drug screening and disease modeling. Recent publications highlight innovations in neurovascular barriers , mechanical memory in cancer metastasis , and glymphatic system studies for neurodegenerative diseases. His lab develops 3D microfluidic platforms to simulate cardiovascular dynamics , neurological disease , and immune cell trafficking . Scientific Awards : National Academy of Engineering Fellow (2020) Shu Chien Achievement Award (2020) Nerem Medal (2018) Huiskes Medal (2015) Everett Moore Baker Award (2001) He has mentored numerous researchers and graduate students, including Ellen Kan and Marie Floryan . His Mechanobiology Lab at MIT pioneers microphysiological systems for vascular, neurological, and oncological applications, partnering with biotech/pharma for translational research.

• Microfluidics
• Bioengineering
• Biomedical Engineering
• +4 more

Dr. Isaac Lee is an Assistant Professor and Nancy and Peter Meinig Family Investigator in the Life Sciences at Cornell University's Meinig School of Biomedical Engineering. He leads the Lee Lab, focusing on interdisciplinary research at the intersection of engineering, biology, and medicine to advance human health. Education : B.S. (Summa Cum Laude) in Chemical Engineering from Seoul National University (2006), M.S. in Pharmacy (2008), Ph.D. in Bioengineering from Johns Hopkins University (2014), and postdoctoral training at Harvard University's Wyss Institute and Boston University (2019). Research Interests include microfluidics, tissue engineering, lymphatic biology, cancer biology, and regenerative medicine. His lab develops 3D organ-on-chip systems to study lymphatic dysfunction, cancer metastasis, and immune diseases, with a focus on mechanistic insights from biological and mechanical cues. His recent articles highlight advancements in lymphatic valve dysfunction modeling, glymphatic system simulations, and biomaterials for cancer metastasis studies. Dr. Lee has received prestigious awards such as the NSF Career Award (2024) and the Tien Excellence in Teaching Award (2023). He teaches core biomedical engineering courses like Introduction to Biomedical Engineering and Cancer and Immuno-Engineering . His lab collaborates on projects like targeting protein mechanisms in lymphedema and advancing biomaterials for therapeutic applications.

Geir Andre RingstadView profile

Associate Professor

• Neuroimaging
• Cerebrospinal Fluid Dynamics
• Glymphatic System
• +3 more

Geir Andre Ringstad is an Associate Professor at the Department of Radiology and Nuclear Medicine , University of Oslo, specializing in neuroimaging and cerebrospinal fluid (CSF) dynamics . His research focuses on the glymphatic system , CSF tracer studies , and MRI-based quantification of brain clearance mechanisms. Research Themes Neurofluid dynamics and glymphatic dysfunction in normal pressure hydrocephalus , Chiari malformation , and pineal cysts Impact of sleep deprivation on CSF tracer clearance Novel MRI protocols for assessing CSF disorders and neuroimmune interfaces Publications cover diverse topics including glymphatic-lymphatic coupling , CSF flow modeling , contrast agent safety , and computational analysis of neurofluid pathways. Collaborative work spans neurosurgery , endocrinology , and biophysics .

Tracy HengView profile

Associate Professor

• Stem Cell Therapy
• Immunology
• Cell Therapy
• +3 more

Associate Professor Tracy Heng is an academic at Monash University, leading research on overcoming immunological barriers in stem cell therapies. She holds a PhD from Monash University and completed postdoctoral training at Harvard Medical School. Her roles include Laboratory Head in the Department of Anatomy & Developmental Biology and Deputy Head of the Immunity Program at the Monash Biomedicine Discovery Institute. Education: PhD, Monash University (strategies to improve immune function in ageing) Postdoctoral training with Professors Harald von Boehmer, Christophe Benoist, and Diane Mathis (Harvard Medical School, Immunological Genome Project) Research Interests: Understanding immune responses to stem cell transplantation, optimizing cell therapies, and addressing immunological challenges. Key areas include mesenchymal stromal cell apoptosis, lymphoid organ roles in therapy, and macrophage biology. Recent Articles: Focus on apoptosis-driven therapeutic mechanisms, stromal cell interactions with lymph nodes, and cytokine effects on cell survival. Recent work highlights the critical role of apoptosis in therapeutic efficacy and the importance of secondary lymphoid organs in cell therapy. Awards: 2015 Young Tall Poppy Science Award 2016 Metcalf Prize for Stem Cell Research 2016 NHMRC R.D. Wright Fellowship 2011 ARC Postdoctoral (Industry) Fellowship Projects: Leading projects such as 'The mesenchymal stromal cell paradox' (2022–2025) and 'Surface coatings for directed differentiation of iPSCs to T-cells' (2023–2026). Collaborates on initiatives like the ARC Training Centre for Cell and Tissue Engineering Technologies. Labs/Teams: Leads a research group focused on immunological barriers in stem cell therapies within the Monash Biomedicine Discovery Institute.

Julia CastleberryView profile

Associate Professor

• Neurological Rehabilitation
• Geriatric Successful Living Strategies
• Falls Prevention
• +4 more

Julia Castleberry is an Associate Professor of Physical Therapy at Emory & Henry University’s School of Health Sciences. She holds a DHSc from Radford University-Carilion (2021) and has over 30 years of clinical and academic experience in neurology, geriatrics, and oncology. Her work focuses on falls prevention, lymphedema therapy, and stroke rehabilitation. She co-founded the Falls Prevention Center, emphasizing lifespan wellness and community programs. Castleberry serves on numerous professional boards, including the American Physical Therapy Association’s Neurology Section and Brain Injury Services of Southwest Virginia. She is a certified Dementia Practitioner, Lymphedema Therapist, and LSVT-BIG provider. Education: Doctor of Health Science (DHSc), Radford University-Carilion (2021) Transitional Doctor of Physical Therapy (t-DPT), Virginia Commonwealth University (2011) Master of Science in Physical Therapy, Duke University (1993) Bachelor of Science in Biology, Virginia Tech (1990) Research & Professional Contributions: Castleberry leads studies on falls prevention, chronic disease management, and telehealth for veterans with brain injuries. Her funded projects include a study on Appalachian Trail hikers’ health and a longitudinal program for Parkinson’s, MS, and obesity patients. She has authored peer-reviewed articles, presented nationally, and developed educational programs like the CLiC-Wounded Warrior initiative. Teaching & Service: She teaches courses in neuroscience, neuromuscular therapy, and rural health. She chairs curricular committees and interprofessional education initiatives at Emory & Henry. Her roles in professional organizations include leadership in the Virginia Physical Therapy Association and APTA Neurology Section.

• Brain Energy Metabolism
• Magnetic Resonance Imaging (MRI)
• Molecular Imaging
• +5 more

Dr. D. S. Fahmeed Hyder is a Professor of Radiology & Biomedical Imaging and Biomedical Engineering at Yale University, with joint appointments in the Yale School of Medicine. He leads the Magnetic Resonance Research Center (MRRC) and directs the Core Center for Quantitative Neuroscience with Magnetic Resonance (QNMR). His research focuses on brain energy metabolism, developing advanced MRI techniques to study neuronal-glial interactions, metabolic dysfunction biomarkers, and molecular imaging of tumors. He holds over 240 peer-reviewed publications and has secured continuous NIH funding for 25+ years. Education: B.A. in Chemistry (Wabash College, 1990), Ph.D. in Biophysical Chemistry (Yale University, 1995). Postdoctoral training includes roles at Oak Ridge National Laboratory, University of Rochester, and Yale. Research Interests: Functional MRI (fMRI) advancements, calibrated fMRI for quantitative neural activity, BIRDS molecular imaging (for pH/temperature), and applications in neurodegenerative diseases (e.g., Alzheimer’s) and oncology. Current projects include pH biosensor development, tumor response monitoring, and neuropil density prediction via AI. Awards: Melvin H. Knisely Award, Niels Lassen Award, Lundbeck Visiting Professorship, and fellowships in AIMBE, ARBR, and Sigma Xi. Recently appointed Head of Trumbull College at Yale. Grants: Continuous NIH support across 7 institutes; active projects in molecular imaging, stroke models, and neurovascular coupling. Labs/Teams: MRRC (mrrc.yale.edu), QNMR (qnmr.yale.edu), collaborating with interdisciplinary teams in physics, engineering, and biology.

Emiel van der VorstView profile

Researcher

• Cardiovascular Research
• Atherosclerosis
• Immunology
• +6 more

Dr. Emiel van der Vorst is a cardiovascular researcher focusing on atherosclerosis, immunometabolism, and translational medicine . His work spans molecular mechanisms, therapeutic targeting, and omics-based approaches. Affiliation: Institute for Molecular Cardiovascular Research (IMCAR) Research Focus: Chemokine signaling, microRNA therapeutics, immune-metabolic interactions Research Trends: Recent publications highlight his exploration of microRNA-26b in metabolic liver disease GPR55 receptor in cardiomyocyte adaptation calcium-sensing receptor in sex-specific atherosclerosis aryl hydrocarbon receptor in gut-liver-cardiovascular axis His work integrates nanomedicine, genetic models, and clinical biomarker development .

Lydia SorokinView profile

Professor

• cell-matrix interactions
• leukocyte extravasation
• blood vessels
• +4 more

Lydia Sorokin is a Professor at the Institute of Physiological Chemistry and Pathobiochemistry within the University of Münster , Germany. She serves as Spokesperson for the Cells in Motion Interfaculty Centre and actively contributes to the Imaging Network and CiM-IMPRS graduate program . Research Focus: Cell-matrix interactions, leukocyte extravasation, blood vessel biology, secondary lymphoid organs, and neuroinflammatory processes. Key Contributions: Elucidating laminin functions in vascular integrity, neuroinflammatory disease mechanisms, and extracellular matrix regulation of immune cell migration. Publication Trends: Recent studies (2022-2024) explore CNS macrophage heterogeneity , endothelial-laminin interactions , and neurovascular unit dysfunction in diseases like multiple sclerosis and cerebral small vessel disease. Earlier work (2012-2020) established roles for laminins and matrix metalloproteinases in blood-brain barrier regulation, immune cell trafficking, and tissue-specific matrix responses. Collaborations & Networks: Active in Cells in Motion , Imaging Network , and CiM-IMPRS graduate program. Collaborates with institutions across Europe on neurovascular and immunology research. Contact: sorokin@uni-muenster.de

• Vascular Biology
• Inflammation
• Atherosclerosis
• +3 more

Hai Feng Zhang is an Associate Research Scientist in the Department of Pathology at Yale University School of Medicine. His research focuses on vascular biology and inflammation-driven diseases, particularly exploring mechanisms of endothelial dysfunction in conditions like atherosclerosis and cerebral cavernous malformations (CCM). He holds a PhD from the National University of Singapore and degrees from China Agricultural University. Education: PhD, National University of Singapore MS, China Agricultural University, Endocrinology BS, China Agricultural University, Biochemistry and Physiology Research Interests: His work investigates how inflammatory signals (e.g., TNF) and reactive oxygen species disrupt endothelial homeostasis. Key areas include: - Molecular mechanisms of vascular inflammation - Role of SUMOylation in vascular remodeling - Mitochondrial dysfunction in endothelial pathologies - CCM pathogenesis and therapeutic targets Key Contributions: Recent studies have uncovered roles for SRF SUMOylation in smooth muscle differentiation and identified mitochondrial pathways (TRX2, ATPIF1) critical for vascular health. Collaborations with teams like the Jenny Zhou Lab advance understanding of brain endothelial progenitor signaling and CCM development. Labs/Teams: Active member of the Jenny Zhou Lab, collaborating on translational vascular research projects.